Peter Vanhoutte

  • Address Cassan, bâtiment A, étage 3, porte 319, case courrier 2, 7 quai Saint Bernard, 75 252 PARIS CEDEX
  • Telephone number +33(0)144275352
  • Email


Peter Vanhoutte (DR1-CNRS)

Lab. Neurosciences Paris-Seine


Team leader: Neuronal Signaling and Gene Regulations

Sorbonne Université, Paris


-2009: Habilitation for research supervision (HDR); Université Pierre & Marie Curie (UPMC).

-2000: PhD in Neuroscience; UPMC.

-1996: DEA in Neuroscience; UPMC


2022-present: DR1-CNRS head of the SNRG team; Lab Neuroscience Paris-Seine CNRS/UMR8246; INSERM/UMRS1130; Sorbonne University (SU; head: Dr H.Chneiweiss).

-2014-2022: DR2-CNRS co-head of the SNRG team with Dr J.Caboche; Lab Neuroscience Paris-Seine CNRS/UMR8246; INSERM/UMRS1130; Sorbonne University (SU; head: Dr H.Chneiweiss).

-2010-2013: CR1-CNRS co-head of the team “Signalisation intracellulaire et Neuroadaptations” with Dr J.Caboche; CNRS/UMR7224; INSERM/UMRS952; UPMC (head: Dr B.Giros)

-2003-2009: CR2/CR1-CNRS in the team « Signalisation Neuronale & Régulations Géniques » headed by Dr J.Caboche ; UMR 7102 ; UPMC – Paris VI ; head : Dr J.Mariani).

-2001-2003: Post-doctoral fellow: Medical Research Council de Cambridge (UK) and department of Neuroscience of Heidelberg University (head Dr H.Bading).

Teaching Activities/ PhD supervision

-2018-2022: Supervision of 4 PhD students. Two of them defended their PhD, one of them is the recipient of a PhD prize from the “Académie Nationale de Pharmacie”.

-2020-present: Co-head, with Pr S.Betuing, of the M2 program “Neuroscience of Psychiatric disorders” at SU and co-organizer/lecturer of the mandatory training unit of this program.

-2015-2019: Lecturer on “Molecular basis of memory” for M2 students at SU.

-Member of the pedagogic team of the doctoral school “Cerveau, Cognition, & Comportement”.

-Regular member of the scientific advisory board of the doctoral school “Biosigne”; Paris-Saclay.

Reviewing activities/Commissions of trust

-Editor at Molecular & Cellular Neuroscience.

-Associate editor at Frontiers in Molecular Neuroscience.

-Reviewer (?3/month) for Biol.Psychiatry,Sci.Rep., Neurobiol. Dis., Neuropharmacology Neurosciences, Mol. Cell. Neurosci., Mol. Basis of Dis. etc…

-Regular grant reviewing for ANR; FRC, FRM, Fundacao para a Ciencia e a tecnologia etc…

-2020-present: Member of the executive board of the i-Bio initiative; IDEX SU.

-Regular member of evaluation panels for “Awards for research” at SU.

-Regular member of PhD/HDR juries as referee, examiner or president (?4/year).


Creation of the company MELKin-Pharma, which R&D activities are based on the valorization of 5 patents of which I am co-inventor. I am co-founder, shareholder, and member of the scientific board of MELKin-Pharma.

@font-face {font-family:Dotum; panose-1:2 11 6 0 0 1 1 1 1 1; mso-font-alt:??; mso-font-charset:129; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1342176593 1775729915 48 0 524447 0;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536859905 -1073697537 9 0 511 0;}@font-face {font-family:"\@Dotum"; panose-1:2 11 6 0 0 1 1 1 1 1; mso-font-charset:129; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1342176593 1775729915 48 0 524447 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText {mso-style-priority:99; mso-style-link:"Corps de texte Car"; margin-top:0cm; margin-right:-23.55pt; margin-bottom:6.0pt; margin-left:0cm; text-align:justify; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri",sans-serif; mso-fareast-font-family:Calibri; mso-bidi-font-family:"Times New Roman"; mso-fareast-language:EN-US;}a:link, span.MsoHyperlink {mso-style-priority:99; color:#0563C1; mso-themecolor:hyperlink; text-decoration:underline; text-underline:single;}a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; mso-style-priority:99; color:#954F72; mso-themecolor:followedhyperlink; text-decoration:underline; text-underline:single;}span.CorpsdetexteCar {mso-style-name:"Corps de texte Car"; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Corps de texte"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-fareast-font-family:Calibri; mso-hansi-font-family:Calibri; mso-bidi-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:0pt; mso-ligatures:none; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}